Serum angiotensin type-1 receptor autoantibodies and neurofilament light chain as markers of neuroaxonal damage in post-COVID patients
These findings highlight the potential of targeting AT1 receptors as a therapeutic strategy for mitigating cognitive deficits in post-COVID patients showing upregulated AT1-AA levels.
Authors
- Tomás Segura (ORCID: https://orcid.org/0000-0003-3625-0987)
- José L. Labandeira‐García (ORCID: https://orcid.org/0000-0002-8243-9791)
- Gemma Serrano‐Heras (ORCID: https://orcid.org/0000-0001-9368-4832)
- Carmen M. Labandeira (ORCID: https://orcid.org/0000-0002-6274-5871)
- Ana I. Rodríguez‐Pérez (ORCID: https://orcid.org/0000-0003-1354-8799)
- María J. Guerra (ORCID: https://orcid.org/0000-0002-6385-9344)
- Beatriz Castro‐Robles (ORCID: https://orcid.org/0000-0001-6441-7735)
- Mónica Muñoz (ORCID: https://orcid.org/0000-0002-5530-2394)
- Juan Suárez‐Quintanilla (ORCID: https://orcid.org/0000-0001-8114-6834)
- Laura Camacho-Meño (ORCID: https://orcid.org/0000-0001-7179-1514)
- Pepa Piqueras-Landete
Institutions
- Universidade de Santiago de Compostela (ES)
- Biomedical Research Networking Center on Neurodegenerative Diseases (ES)
- Instituto de Biomedicina y Biotecnología de Cantabria (ES)
- Center for Research in Molecular Medicine and Chronic Diseases (ES)
- Hospital General Universitario de Albacete (ES)
- Instituto de Investigación Sanitaria de Santiago (ES)
- Complejo Hospitalario de Ourense (ES)
- University of Castilla-La Mancha (ES)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-04-22
- DOI
- https://doi.org/10.3389/fimmu.2025.1571027
- Citations
- 4
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 5.56
Funders
- Ministerio de Ciencia, Innovación y Universidades
- Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas
- Instituto de Salud Carlos III